【発明の名称】Xa因子を阻害する複素環誘導体

Title:

【発明の名称】Xa因子を阻害する複素環誘導体

Document Type and Number:

Japanese Patent JP2002513790

Kind Code:

A

Abstract:

The invention relates to heterocyclic derivatives of formula (I), or pharmaceutically-acceptable salts thereof, which possess antithrombotic and anticoagulant properties and are accordingly useful in methods of treatment of humans or animals. The invention also relates to processes for the preparation of the heterocyclic derivatives, to pharmaceutical compositions containing them and to their use in the manufacture of medicaments for use in the production of an antithrombotic or anticoagulant effect.

More Like This:

JP4219590	Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
WO/2012/068483	PRESELECTION OF SUBJECTS FOR THERAPEUTIC TREATMENT BASED ON HYPOXIC STATUS
JPH01226818	MEMORY ENHANCER OR MEMORY DISORDER TREATMENT AGENT COMPOSED OF ARYLAMIDE AZABICYCLOALKANES AND ARYLTHIOAMIDE AZABICYCLOALKANES

Inventors:

Colecket, Peter William Rodney
James, roger
Pearson, Stuart Eric
Slater, Anthony Michael
Walker, Rolf Peter

Application Number:

JP2000547083A

Publication Date:

May 14, 2002

Filing Date:

April 27, 1999

Export Citation:

Click for automatic bibliography generation Help

Assignee:

AstraZeneca Activrag

International Classes:

A61K31/395; A61K31/496; A61K31/50; A61K31/501; A61K31/506; A61K31/5377; A61K31/541; A61P7/02; A61P9/00; A61P9/10; C07D405/12; A61P43/00; C07D401/10; C07D401/12; C07D403/12; C07D413/02; C07D413/12; C07D417/02; C07D471/04; C07D491/04; A61K; C07D; (IPC1-7): C07D405/12; A61K31/496; A61K31/501; A61K31/506; A61P7/02; A61P9/00; A61P9/10; A61P43/00; C07D401/12; C07D403/12

Attorney, Agent or Firm:

Kazuo Shamoto (5 outside)

Previous Patent: １−（６−クロロナフト−２−イルスルホニル）−４−［４−（４−ピリ�...

Next Patent: 新規ベンズイミダゾールおよびベンズオキサゾール